Who owns Rigel Pharmaceuticals?
- CUSIP Number: 766559603
Tip: Access positions for across all investors
Analyze quarterly positions in Rigel Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Rigel Pharmaceuticals stock
Who bought or sold Rigel Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Advisory Services Network | 44k | $1.9M | 38% | Dec 2025 |
|
| Hughes Financial Services | 1.6k | $43k | 60% | Mar 2026 |
|
| Farther Finance Advisors | 752.00 | $21k | -3% | Mar 2026 |
|
| Parallel Advisors | 340.00 | $9.2k | 342% | Mar 2026 |
|
| Versant Capital Management | 237.00 | $6.4k | 6% | Mar 2026 |
|
| EverSource Wealth Advisors | 218.00 | $5.9k | 707% | Mar 2026 |
|
| Huntington National Bank | 1.00 | $1.000000 | 0% | Dec 2025 |
|
| Rothschild Investment | 1.00 | $27.000000 | -88% | Mar 2026 |
|
Who sold out of Rigel Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Triumph Capital Management | Dec 2025 | 200.00 | $8.6k |